Commentary to Impact of Sacubitril-Valsartan Treatment on Diastolic Function in Patients with Heart Failure and Reduced Ejection Fraction

被引：0
|
作者：
Agata Buonacera
Benedetta Stancanelli
Lorenzo Malatino
机构：
[1] University of Catania,Academic Unit of Internal Medicine and Hypertension Centre, Department of Clinical and Experimental Medicine
[2] c/o Cannizzaro Hospital,undefined
来源：
High Blood Pressure & Cardiovascular Prevention | 2021年 / 28卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：331 / 332
页数：1
相关论文
共 50 条
  • [41] Use of Sacubitril/Valsartan in heart failure with reduced ejection fraction
    吴利强
    冯慧婷
    冯慧娟
    South China Journal of Cardiology, 2019, 20 (04) : 252 - 257
  • [42] Economic evaluation of sacubitril/valsartan for the treatment of heart failure with reduced ejection fraction
    Stafylas, P.
    Farmakis, D.
    Giamouzis, G.
    Hatzikou, M.
    Kourlaba, G.
    Papatsouma, I.
    Maniadakis, N.
    EUROPEAN HEART JOURNAL, 2016, 37 : 730 - 731
  • [43] Focused Treatment of Heart Failure with Reduced Ejection Fraction Using Sacubitril/Valsartan
    Rex C. Liu
    American Journal of Cardiovascular Drugs, 2018, 18 : 473 - 482
  • [44] LIVER FUNCTION AND PROGNOSIS, AND INFLUENCE OF SACUBITRIL/VALSARTAN IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION
    Suzuki, Kota
    Claggett, Brian
    Minamisawa, Masatoshi
    Packer, Milton
    Zile, Michael
    Rouleau, Jean L.
    Swedberg, Karl
    Lefkowitz, Martin
    Shi, Victor
    McMurray, John
    Solomon, Scott D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 800 - 800
  • [45] Liver function and prognosis, and influence of sacubitril/valsartan in patients with heart failure with reduced ejection fraction
    Suzuki, Kota
    Claggett, Brian
    Minamisawa, Masatoshi
    Packer, Milton
    Zile, Michael R.
    Rouleau, Jean
    Swedberg, Karl
    Lefkowitz, Martin
    Shi, Victor
    McMurray, John J., V
    Zucker, Stephen D.
    Solomon, Scott D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (09) : 1662 - 1671
  • [46] Effects of sacubitril/valsartan on right ventricular function in patients with heart failure and reduced ejection fraction
    Polito, Maria Vincenza
    D'Auria, Federica
    Cogliani, Francesco Maria
    Loria, Francesco
    Vitulano, Gennaro
    De Angelis, Elena
    Rispoli, Antonella
    Silverio, Angelo
    Citro, Rodolfo
    Vecchione, Carmine
    Galasso, Gennaro
    Ciccarelli, Michele
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0J) : J125 - J125
  • [47] Sacubitril/Valsartan in the primary treatment of heart failure with reduced ejection fraction (HFrEF)
    Nowak, Bernd
    Geiss, Ernst
    Boehm, Michael
    Weil, Joachim
    Boer, Jana
    KARDIOLOGIE, 2023, : 44 - 48
  • [48] Current evidence of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction
    Abumayyaleh, Mohammad
    El-Battrawy, Ibrahim
    Behnes, Michael
    Borggrefe, Martin
    Akin, Ibrahim
    FUTURE CARDIOLOGY, 2020, 16 (04) : 227 - 236
  • [49] Focused Treatment of Heart Failure with Reduced Ejection Fraction Using Sacubitril/Valsartan
    Liu, Rex C.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2018, 18 (06) : 473 - 482
  • [50] Sacubitril-valsartan improves conduit vessel function and functional capacity and reduces inflammation in heart failure with reduced ejection fraction
    Bunsawat, Kanokwan
    Ratchford, Stephen M.
    Alpenglow, Jeremy K.
    Park, Soung Hun
    Jarrett, Catherine L.
    Stehlik, Josef
    Smith, Adam S.
    Richardson, Russell S.
    Wray, D. Walter
    JOURNAL OF APPLIED PHYSIOLOGY, 2021, 130 (01) : 256 - 268
12345